SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • November 13th, 2014 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 13th, 2014 Company Industry JurisdictionThis Securities Exchange Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is dated as of November 12, 2014 and is entered into by and between NAVIDEA BIOPHARMACEUTICALS, INC. (the “Company”), and PLATINUM PARTNERS VALUE ARBITRAGE FUND, L.P. (“Platinum”).